Screener
AbbVie ABBV Share Repurchase Program - Amount Remaining
Share Repurchase Program - Amount Remaining at other companies
Other financials
Where this comes from
Reported directly by AbbVie in its filing.
Tagged under the XBRL concept us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1.
The source filing: AbbVie’s 10-Q, filed May 8, 2026.
- Filed
- May 8, 2026, 12:28 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001551152-26-000017
AbbVie repurchased 5 million shares for $1.1 billion during the three months ended March 31, 2026 and 3 million shares for $606 million during the three months ended March 31, 2025. AbbVie's remaining stock repurchase authorization was approximately $1.8 billion as of March 31, 2026.
ITEM 1. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA
FAQ
- What is AbbVie's share repurchase program - amount remaining?
- AbbVie (ABBV) reported share repurchase program - amount remaining of $1.8B in Q1 2026.
- How has AbbVie's share repurchase program - amount remaining changed year-over-year?
- AbbVie's share repurchase program - amount remaining decreased by 37.9% year-over-year, from $2.9B to $1.8B.
Ask your AI about AbbVie's share repurchase program - amount remaining.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude